| Name | Title | Contact Details |
|---|
Johns Hopkins Healthcare is a Glen Burnie, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
DR Management is a Fort Wayne, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Design Clinicals is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Tukwila, WA. To find more information about Design Clinicals, please visit www.designclinicals.com
NantCel is an offshoot of Soon-Shiong`s NantWorks conglomerate. Developing molecular-level cell-based treatments for diseases.